Kraig Biocraft Laboratories Announces Monster Silk(TM) Production at Quantities Necessary for Producing Textile Prototypes

Company to Increase Scale of Its Recombinant Spider Silk Production

LANSING, Mich., August 19, 2013 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (KBLB) (“Company”), the leading developer of advanced spider silk based fibers, today announced that the Company’s pilot production program has successfully produced a sufficient quantity of Monster Silk(TM) cocoons to allow the Company to make the first Monster Silk(TM) textile prototypes.

The cocoons still need to be reeled and processed into yarn before the first prototype and sample textiles can be produced. The announcement puts the Company firmly ahead of its most recent textile production schedule. The first textiles are slated for mechanical testing of the properties of recombinant spider silk in various textile knits and/or weaves.

The Company also announced today a change in its production schedule and scale of operations for its initial commercial production program. “The timing of cocoon production from the pilot program worked out well, because we were getting indications from the field that the weather developing in August was not ideal for the mulberry production needed for our commercial launch,” said Company founder and CEO, Kim K. Thompson. “We are going to take advantage of the fact that with this supply of cocoons we have bought ourselves some breathing room. The Company plans to delay the launch of commercial production until sometime in September. We can now do this with no expected impact on our schedule to produce new textiles. By moving the production launch to September we may also be in a position to increase the scale of the initial commercial production by a factor of two or more. The Laboratory is taking full advantage of the time by working on egg production in order to increase the scale of the commercial launch.”

“The pilot production program was the first time that we raised Monster Silk(TM) silkworms in real world conditions,” continued Thompson. “The success of that program has enabled us to prepare for the creation of recombinant spider silk textiles and to increase the scale of our pending launch of spider silk production on a commercial scale.”

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (, a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.


Ben Hansel, Hansel Capital, LLC.
(720) 288-8495

This entry was posted on by .